Andri Halim

Andri Halim has extensive experience in quality assurance and management roles in the pharmaceutical industry. Andri is currently the Senior Director of Quality at Scorpion Therapeutics since July 2023. Prior to this, they worked at Foghorn Therapeutics Inc. as the Senior Director of Quality Assurance from August 2022 to July 2023, and as the Director of Quality Assurance from March 2021 to August 2022.

Before joining Foghorn Therapeutics Inc., Andri held various positions at Agios Pharmaceuticals, including Director of GMP QA from October 2019 to March 2021, Associate Director of Quality Assurance from June 2017 to October 2019, Senior Manager of Quality Assurance from July 2015 to June 2017, and Quality Assurance Manager from December 2013 to July 2015.

Andri also worked as a QA Manager at ARIAD Pharmaceuticals, Inc. from September 2013 to December 2013, and at Millennium Pharmaceuticals as Manager I of Investigational QA from July 2011 to September 2013, and QA Specialist III of Investigational QA from December 2008 to July 2011.

Andri began their career as a Compliance Specialist at deCODE chemistry from July 2006 to November 2008, and as an Advanced Quality Technician at Abbott Laboratories from 2003 to 2006.

Andri Halim obtained a Bachelor of Science in Chemical Engineering from the Illinois Institute of Technology between 2000 and 2002.